The emerging role of large immunophilin FK506 binding protein 51 in cancer

Current Medicinal Chemistry

Volumn 18, Issue 35, 2011, Pages 5424-5429

  Romano, S ^a   Sorrentino, A ^a   Di Pace, A L ^a   Nappo, G ^a   Mercogliano, C ^a   Romano, M F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Apoptosis; Cancer; FKBP51; NF B; Rapamycin

Indexed keywords

ANDROGEN RECEPTOR; ATORVASTATIN; CALCINEURIN; CHAPERONE; DOXORUBICIN; ESTROGEN RECEPTOR; EVEROLIMUS; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOPHILIN; INTERLEUKIN 2; JANUS KINASE 2; MAMMALIAN TARGET OF RAPAMYCIN; MOLECULAR SCAFFOLD; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; RAPAMYCIN; RIDAFOROLIMUS; STAT5 PROTEIN; TAU PROTEIN; TEMSIROLIMUS; TRANSCRIPTION FACTOR RELA; TUMOR PROMOTER; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONFOCAL MICROSCOPY; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IONIZING RADIATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPHATIC LEUKEMIA; MELANOMA; MESENCHYME CELL; MYELOID METAPLASIA; NEUROPROTECTION; NONHUMAN; OVARY CANCER; OXIDATIVE STRESS; PROMYELOCYTIC LEUKEMIA; PROSTATE CARCINOMA; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RETINA TUMOR; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MELANOMA; NEOPLASMS; NF-KAPPA B; TACROLIMUS BINDING PROTEINS;

EID: 82255173727     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711798194333     Document Type: Article

References (81)

1. Dornan, J.; Taylor, P.; Walkinshaw, M. D. Structures of Immunophilins and their Ligand Complexes. Current Topics in Medicinal Chemistry, 2003, 3(12), 1392-1409.
2. Fischer, G.; Aumüller, T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev Physiol Biochem Pharmacol, 2003, 148, 105-150.
3. Somarelli, J. A.; Lee, S. Y.; Skolnick, J.; Herrera, R. J. Structure-based classification of 45 FK506-binding proteins. Proteins, 2008, 72(1), 197-208. (Pubitemid 351809158)
4. Sabatini, D. M. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer, 2006, 6(9), 729-734. (Pubitemid 44286004)
5. Yamamoto, M.; Baba, H.; Kusumoto, T.; Sakaguchi, Y.; Maehara, Y.; Kuwano, M.; Sugimachi, K. Cyclosporin A and FK506 reverse anthracycline resistance by altering the cell cycle. Anticancer Drugs, 1995, 6(4), 570-577.
6. Periyasamy, S.; Hinds, T. Jr.; Shemshedini, L.; Shou, W.; Sanchez, E. R. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Oncogene, 2010, 29(11), 1691-1701.
7. Cloughesy, T. F.; Yoshimoto, K.; Nghiemphu, P.; Brown, K.; Dang, J.; Zhu, S.; Hsueh, T.; Chen, Y.; Wang, W.; Youngkin, D.; Liau, L.; Martin, N.; Becker, D.; Bergsneider, M.; Lai, A.; Green, R.; Oglesby, T.; Koleto, M.; Trent, J.; Horvath, S.; Mischel, P. S.; Mellinghoff, I. K.; Sawyers, C. L. Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med, 2008, 5(1), e8.
8. Avellino, R.; Romano, S.; Parasole, R.; Bisogni, R.; Lamberti, A.; Poggi, V.; Venuta, S.; Romano, M. F. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. Blood, 2005, 106(4), 1400-1406. (Pubitemid 41129607)
9. Romano, M. F.; Avellino, R.; Petrella, A.; Bisogni, R.; Romano, S.; Venuta, S. Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells. Eur J Cancer, 2004, 40(18), 2829-2836. (Pubitemid 39574738)
10. Hudes, G.; Carducci, M.; Tomczak, P.; Dutcher, J.; Figlin, R.; Kapoor, A.; Staroslawska, E.; Sosman, J.; McDermott, D.; Bodrogi, I.; Kovacevic, Z.; Lesovoy, V.; Schmidt-Wolf, I. G.; Barbarash, O.; Gokmen, E.; O'Toole, T.; Lustgarten, S.; Moore, L.; Motzer, R. J. Global ARCC Trial. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med, 2007, 356(22), 2271-81. (Pubitemid 46849157)
11. Schmelzle, T.; Hall, M. N. TOR, a central controller of cell growth. Cell, 2000, 103(2), 253-262.
12. Jiang, W.; Cazacu, S.; Xiang, C.; Zenklusen, J. C.; Fine, H. A.; Berens, M.; Armstrong, B.; Brodie, C.; Mikkelsen, T. FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway. Neoplasia, 2008, 10(3), 235-243. (Pubitemid 351337518)
13. Baughman, G.; Wiederrecht, G. J.; Faith Campbell, N.; Martin, M. M.; Bourgeois, S. FKBP51, a novel T-cell specific immunophilin capable of calcineurin inhibition. Mol Cell Biol, 1995, 15(8), 4395-4402.
14. Hogan, P. G.; Chen, L.; Nardone, J.; Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev, 2003, 17(18), 2205-2232. (Pubitemid 37128637)
15. Weiwad, M.; Edlich, F.; Kilka, S.; Erdmann, F.; Jarczowski, F.; Dorn, M.; Moutty, M. C.; Fischer, G. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins. Biochemistry, 2006, 45(51), 15776-15784. (Pubitemid 46032498)
16. Cheung-Flynn, J.; Roberts, P. J.; Riggs, D. L.; Smith, D. F. C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90. J Biol Chem, 2003, 278(19), 17388-17394. (Pubitemid 36799624)
17. Cheung, J.; Smith, D. F. Molecular chaperone interactions with steroid receptors: an update. Mol Endocrinol, 2000, 14(7), 939-946. (Pubitemid 32250512)
18. Riggs, D. L.; Roberts, P. J.; Chirillo, S. C.; Cheung-Flynn, J.; Prapapanich, V.; Ratajczak, T.; Gaber, R.; Picard, D.; Smith, D. F. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J, 2003, 22(5), 1158-1167. (Pubitemid 36313599)
19. Tai, P. K.; Maeda, Y.; Nakao, K.; Wakim, N. G.; Duhring, J. L.; Faber, L. E. A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry, 1986, 5269-5275. (Pubitemid 17016541)
20. Gallo, L. I.; Ghini, A. A.; Pilipuk, G. P.; Galigniana, M. D. Differential Recruitment of Tetratricorpeptide Repeat Domain Immunophilins to the Mineralocorticoid Receptor Influences both Heat-Shock Protein 90-Dependent Retrotransport and Hormone-Dependent Transcriptional Activity. Biochemistry, 2007, 46, 14044-14057. (Pubitemid 350250300)
21. Febbo, P. G.; Lowenberg, M.; Thorner, A. R.; Brown, M.; Loda, M.; Golub, T. R. Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. J Urol, 2005, 173, 1772-1777. (Pubitemid 40524830)
22. Binder, E. B.; Salyakina, D.; Lichtner, P.; Wochnik, G. M.; Ising, M.; Pütz, B.; Papiol, S.; Seaman, S.; Lucae, S.; Kohli, M. A.; Nickel, T.; Künzel, H. E.; Fuchs, B.; Majer, M.; Pfennig, A.; Kern, N.; Brunner, J.; Modell, S.; Baghai, T.; Deiml, T.; Zill, P.; Bondy, B.; Rupprecht, R.; Messer, T.; Köhnlein, O.; Dabitz, H.; Brückl, T.; Müller, N.; Pfister, H.; Lieb, R.; Mueller, J. C.; Lãhmussaar, E.; Strom, T. M.; Bettecken, T.; Meitinger, T.; Uhr, M.; Rein, T.; Holsboer, F.; Muller-Myhsok, B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet, 2004, 36(12), 1319-1325. (Pubitemid 39577942)
23. Gallo, L. I.; Lagadari, M.; Piwien-Pilipuk, G.; Galigniana, M. D. The 90-kDa Heat-shock Protein (Hsp90)-binding Immunophilin FKBP51 Is a Mitochondrial Protein That Translocates to the Nucleus to Protect Cells against Oxidative Stress. J Biol Chem, 2011, 286(34), 30152-30160.
24. Jinwal, U. K.; Koren, J 3rd.; Borysov, S. I.; Schmid, A. B.; Abisambra, J. F.; Blair, L. J.; Johnson, A. G.; Jones, J. R.; Shults, C. L.; O'Leary, J. C 3rd.; Jin, Y.; Buchner, J.; Cox, M. B.; Dickey, C. A. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules. J Neurosci, 2010, 30(2), 591-599.
25. Goedert, M.; Wischik, C. M.; Crowther, R. A.; Walker, J. E.; Klug, A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA, 2000, 85(11), 4051-4055.
26. Alonso, A.; Zaidi, T.; Novak, M.; Grundke-Iqbal, I.; Iqbal, K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA, 2001, 98(12), 6923-6928. (Pubitemid 32538318)
27. Vittorioso, P.; Cowling, R.; Faure, J. D.; Caboche, M.; Bellini, C. Mutation in the Arabidopsis PASTICCINO1 gene, which encodes a new FK506-binding protein-like protein, has a dramatic effect on plant development. Molecular and Cellular biology, 1998, 18(5), 3034-3043. (Pubitemid 28183472)
28. Liu, T. M.; Martina, M.; Hutmacher, D. W.; Hui, J. H.; Lee, E. H.; Lim, B. Identification of common pathways mediating differentiation of bone marrow-and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem cells, 2007, 25(3), 750-760. (Pubitemid 46354235)
29. Menicanin, D.; Bartold, P. M.; Zannettino, A. C.; Gronthos, S. Genomic profiling of mesenchymal stem cells. Stem Cell Rev, 2009, 5(1), 36-50.
30. Yeh, W. C.; Li, T. K.; Bierer, B. E.; McKnight, S. L. Identification and characterization of an immunophilin expressed during the clonal expansion phase of adipocyte differentiation, 1995, 92(24), 11081-11085.
31. Yeh, W. C.; Bierer, B. E.; McKnight, S. L. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad U S A, 1995, 92(24), 11086-11890.
32. Zhang, T.; Xiong, H.; Kan, L. X.; Zhang, C. K.; Jiao, X. F.; Fu, G.; Zhang, Q. H.; Lu, L.; Tong, J. H.; Gu, B. W.; Yu, M.; Liu, J. X.; Licht, J.; Waxman, S.; Zelent, A.; Chen, E.; Chen, S. J. Genomic sequence, structural organization, molecular evolution and abberrant rearrangement of promyelocytic leukemia zinc finger gene. Proc Natl Acad Sci U S A, 1999, 96(20), 11422-11427. (Pubitemid 29487396)
33. Giraudier, S.; Chagraoui, H.; Komura, E.; Barnache, S.; Blanchet, B.; LeCouedic, J. P.; Smith, D. F.; Larbret, F.; Taksin, A. L.; Moreau-Gachelin, F.; Casadevall, N.; Tulliez, M.; Hulin, A.; Debili, N.; Vainchenker, W. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood, 2002, 100(8), 2932-2940.
34. Komura, E.; Chagraoui, H.; Mansat de Mas, V.; Blanchet, B.; de Sepulveda, P.; Larbret, F.; Larghero, J.; Tulliez, M.; Debili, N.; Vainchenker, W.; Giraudier S. Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression. Exp Hematol, 2003, 31(7), 622-630. (Pubitemid 36808805)
35. Komura, E.; Tonetti, C.; Penard-Lacronique, V.; Chagraoui, H.; Lacout, C.; Lecouédic, J. P.; Rameau, P.; Debili, N.; Vainchenker, W.; Giraudier S. Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression. Cancer Res, 2005, 65(8), 3281-3289. (Pubitemid 40524612)
36. Romano, S.; Mallardo, M.; Romano, M. F. FKBP51 and the NF-kappaB regulatory pathway in cancer. Curr Opin Pharmacol, 2011, 11(4), 288-293.
37. Bouwmeester, T.; Bauch, A.; Ruffner, H.; Angrand, P. O.; Bergamini, G.; Croughton, K.; Cruciat, C.; Eberhard, D.; Gagneur, J.; Ghidelli, S.; Hopf, C.; Huhse, B.; Mangano, R.; Michon, A. M.; Schirle, M.; Schlegl, J.; Schwab, M.; Stein, M. A.; Bauer, A.; Casari, G.; Drewes, G.; Gavin, A. C.; Jackson, D. B.; Joberty, G.; Neubauer, G.; Rick, J.; Kuster, B.; Superti-Furga G. A physical and functional map of the human TNF-alpha/NF-kappaB signal transduction pathway. Nat Cell Biol, 2004, 6(2), 97-105. (Pubitemid 38425708)
38. Auphan, N.; Di Donato, J. A.; Rosette, C.; Helmberg, A.; Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science, 1995, 270(5234), 286-290.
39. Ray, A.; Prefontaine, K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. P roc Natl Acad Sci U S A, 1994, 91(2), 752-756. (Pubitemid 24041480)
40. Scheinman, R. I.; Gualberto, A.; Jewell, CM.; Cidlowski, J. A.; Baldwin, A. S. Jr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol, 1995, 15(2), 943-953.
41. Caldenhoven, E.; Liden, J.; Wissink, S.; Van de Stolpe, A.; Raaijmakers, J.; Koenderman, L.; Okret, S.; Gustafsson, J. A.; Van der Saag, PT. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol, 1995, 9(4), 401-412.
42. Wissink, S.; van Heerde, E. C.; van der Burg, B.; van der Saag, PT. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids. Mol Endocrinol, 1998, 12(3), 355-363. (Pubitemid 30666266)
43. Baldwin, A. S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol, 1996, 14, 649-683. (Pubitemid 26130197)
44. Ghosh, S.; May, M. J.; Kopp, E. B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune response. Annu Rev Immunol, 1998, 16, 225-260. (Pubitemid 28183365)
45. Karin, M.; Cao, X.; Greten, F. R.; Li, Z. W. NF-kappaB in cancer: from innocent bystander to major culprit, Nat Rev Cancer, 2002, 2(4), 301-310. (Pubitemid 37328783)
46. Xiao, G.; Harhaj, E. W.; Sun, S. C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell, 2001, 7(2), 401-409. (Pubitemid 32206507)
47. Huang, W. C.; Ju, T. K.; Hung, M. C.; Chen, C. C. Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB. Molecular Cell, 2007, 26(1), 75-87.
48. Giordano, A.; Avellino, R.; Ferraro, P.; Romano, S.; Corcione, N.; Romano, M. F. Rapamycin Antagonizes NF-kappaB Nuclear Translocation Activated by TNF-alpha in Primary Vascular Smooth Muscle Cells and Enhances Apoptosis. Am. J Phys Heart and Circulatory Phys, 2006, 290(6), H2459-65. (Pubitemid 43846076)
49. Romano, S.; D'Angelillo, A.; Pacelli, R.; Staibano, S.; De Luna, E.; Bisogni, R.; Eskelinen, E. L.; Mascolo, M.; Calì, G.; Arra, C.; Romano, M. F. Role of FK506 binding protein 51 (FKBP51) in the Control of Apoptosis of Irradiated Melanoma Cells. Cell Death and Differentiation, 2010, 17(1), 145-157.
50. Pei, H.; Li, L.; Fridley, B. L.; Jenkins, G. D.; Kalari, K. R.; Lingle, W.; Petersen, G.; Lou, Z.; Wang, L. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell, 2009, 16(3), 259-266.
51. Romano, S.; D'Angelillo, A.; Staibano, S.; Ilardi, G.; Romano, M. F. FK506-binding protein 51 is a possible novel tumoral marker. Cell Death and Disease, 2010, 1, e55, doi:10.1038/cddis.2010.32.
52. Mistafa, O.; Ghalali, A.; Kadekar, S.; Högberg, J.; Stenius, U. Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases. J Biol Chem, 2010, 285(36), 27900-27910.
53. Baughman, G.; Wiederrecht, G. J.; Chang, F.; Martin, MM.; Bourgeois, S. Tissue distribution and abundance of human FKBP51, an FK506-binding protein that can mediate calcineurin inhibition. Biochem Biophys Res Commun, 1997, 232(2), 437-443. (Pubitemid 27216235)
54. Daudt DR, Yorio T. FKBP51 protects 661w cell culture from staurosporineinduced apoptosis. Mol Vis. 2011, 17:1172-1181.
55. Ni, L.; Yang, C. S.; Gioeli, D.; Frierson, H.; Toft, D. O.; Paschal, BM. FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells. Mol Cell Biol, 2010, 30(5), 1243-1253.
56. Ammirante, M.; Luo, J. L.; Grivennikov, S.; Nedospasov, S.; Karin, M. B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature, 2010, 464(7286), 302-305.
57. Choi, J.; Chen, J.; Schreiber, S. L.; Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science, 1996, 273(5272), 239-242. (Pubitemid 26285890)
58. Brown, E. J.; Albers, M. W.; Shin, T. B.; Ichikawa, K.; Keith, C. T.; Lane, W. S.; Schreiber, S. L. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature, 1994, 369(6483), 756-758.
59. Price, D. J.; Grove, J. R.; Calvo, V.; Avruch, J.; Bierer, B. E. Rapamycininduced inhibition of the 70-kilodalton S6 protein kinase. Science, 1992, 257(5072), 973-977.
60. Gingras, A. C.; Raught, B.; Gygi, S. P.; Niedzwiecka, A.; Miron, M.; Burley, S. K.; Polakiewicz, R. D.; Wyslouch-Cieszynska, A.; Aebersold, R.; Sonenberg, N. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev, 2001, 15(21), 2852-2864. (Pubitemid 33042055)
61. Gingras, A. C.; Raught, B.; Sonenberg, N. Regulation of translation initiation by FRAP/mTOR. Genes Dev, 2001, 15(7), 807-826. (Pubitemid 32295062)
62. Burgering, B. M.; Coffer, P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 1995, 376(6541), 599-602.
63. Gao, X.; Pan, D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev, 2001, 15(11), 1383-1392. (Pubitemid 32524645)
64. Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y.; Mills, G. B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery, 2005, 4(12), 988-1004.
65. Wu, X.; Senechal, K.; Neshat, M. S.; Whang, Y. E.; Sawyers, C. L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A, 1998, 95(26), 15587-15591. (Pubitemid 29018743)
66. Mita, M. M.; Mita, A.; Rowinsky, E. K. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol Ther, 2003, 2, S169-77.
67. Neshat, M. S.; Mellinghoff, I. K.; Tran, C.; Stiles, B.; Thomas, G.; Petersen, R.; Frost, P.; Gibbons, J. J.; Wu, H.; Sawyers, C. L. Sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci U S A, 2001, 98(18), 10314-10319. (Pubitemid 32803017)
68. Wu, H.; Goel, V.; Haluska, F. G. PTEN signaling pathways in melanoma. Oncogene, 2003, 22(20), 3113-22. (Pubitemid 36713763)
69. Catz, S. D.; Johnson, J. L. Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene, 2001, 20(50), 7342-7351. (Pubitemid 33078205)
70. Wu, M. X.; Ao, Z.; Prasad, K. V. S.; Wu, R.; Schlossman, S. F. IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science, 1998, 281(5379), 998-999.
71. Lopes de Menezes, D. E.; Hu, Y.; Mayer, L. D. Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice. J Exp Ther Oncol, 2003, 3(2), 72-82. (Pubitemid 36702520)
72. Vaziri, S. A.; Grabowski, D. R.; Tabata, M.; Holmes, K. A.; Sterk, J.; Takigawa, N.; Bukowski, R. M.; Ganapathi, M. K.; Ganapathi, R. c-IAP1 is overexpressed in HL-60 cells selected for doxorubicin resistance: effects on etoposide-induced apoptosis. Anticancer Res, 2003, 23(5A), 3657-3661. (Pubitemid 37474308)
73. Watowich, S. S.; Wu, H.; Socolovsky, M.; Klingmuller, U.; Constantinescu, S. N.; Lodish, H. F. Cytokine receptor signal transduction and the control of hematopoietic cell development. Ann Rev Cell Develop Biol, 1996, 12, 91-128. (Pubitemid 26422710)
74. Romano, M. F.; Romano, S.; Mallardo, M.; Bisogni, R.; Venuta, S. Rapamycin controls multiple signalling pathways involved in cancer cell survival. Cell Apoptosis Research Trends. Nova Publishers, 2007, 263-276.
75. Eskelinen, E. L. New insights into the mechanisms of macroautophagy in mammalian cells. Int Rev Cell Mol Biol, 2008, 266, 207-247.
76. Zhou, S.; Schuetz, J. D.; Bunting, K. D.; Colapietro, A. M.; Sampath, J.; Morris, J. J.; Lagutina, I.; Grosveld, G. C.; Osawa, M.; Nakauchi, H.; Sorrentino, B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med, 2001, 7(9), 1028-1034. (Pubitemid 32937383)
77. Monzani, E.; Facchetti, F.; Galmozzi, E.; Corsini, E.; Benetti, A.; Cavazzin, C.; Gritti, A.; Piccinini, A.; Porro, D.; Santinami, M.; Invernici, G.; Parati, E.; Alessandri, G.; La Porta, C. A. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer, 2007, 43(5), 935-946. (Pubitemid 46366698)
78. Baumann, M.; Krause, M.; Hill, R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer, 2008, 8, 545-54. (Pubitemid 351881850)
79. Yu, L.; McPhee, C. K.; Zheng, L.; Mardones, G. A.; Rong, Y.; Peng, J.; Mi, N.; Zhao, Y.; Liu, Z.; Wan, F.; Hailey, D. W.; Oorschot, V.; Klumperman, J.; Baehrecke, E. H.; Lenardo, M. J. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature, 2010, 465(7300), 942-946.
80. Mathew, R.; Karantza-Wadsworth, V.; White, E. Role of autophagy in cancer. Nat Rev Cancer, 2007, 7(12), 961-967. (Pubitemid 350165856)
81. Brewer, J. K. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm. J Mol Neurosc, 2008, 35(3), 307-322.